Clinical Clarity

One Molecule at a Time

Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.

Learn More

Clinical Lab Testing Services
Clinical Diagnostics System

Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Press Releases

  • July 14, 2015
    Singulex Demonstrates Ultrasensitive “Sgx ClarityTM System” at AACC 2015
  • May 21, 2015
    Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMCTM) Technology

Upcoming Events

  • Oct 21, 2015 - Oct 24, 2015:
    Cardiometabolic Health Congress
    Exhibit Booth #417 Boston, MA
  • Dec 11, 2015 - Dec 13, 2015:
    A4M American Academy of Anti-Aging Medicine
    Exhibit Booth #5060 Las Vegas, NV